Marcella Sarzotti‐Kelsoe
Papers
1
Total Citations
20
H-Index
1
About
Dr. Marcella Sarzotti-Kelsoe is a leading immunologist whose work has been pivotal in standardizing global HIV vaccine trials. Her research centers on the development and validation of high-throughput, reproducible assays for evaluating HIV-specific immune responses, particularly neutralizing antibodies. Her major contribution is the creation of an automated HIV-1 Env-pseudotyped virus production system, a critical tool that ensures consistent, high-quality reagents for laboratories worldwide. This innovation, detailed in her highly cited 2012 paper (20 citations), directly addresses the need for standardized assessments in vaccine trials, enabling reliable comparison of vaccine candidates across different studies and sites. By establishing these rigorous quality control and assay performance benchmarks, Dr. Sarzotti-Kelsoe has significantly enhanced the efficiency and accuracy of the global HIV vaccine pipeline. Her work has been instrumental in the operations of the NIH-funded HIV Vaccine Trials Network (HVTN), where she has led the Central Immunology Laboratory. Through her dedication to assay harmonization and quality assurance, she has provided the scientific community with the robust tools necessary to prioritize the most promising vaccine candidates in the fight against HIV.
Research Focus
Key Achievements
Top Papers
- 1